Your browser doesn't support javascript.
loading
Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab.
Santegoets, Saskia Jam; Stam, Anita Gm; Lougheed, Sinéad M; Gall, Helen; Jooss, Karin; Sacks, Natalie; Hege, Kristen; Lowy, Israel; Scheper, Rik J; Gerritsen, Winald R; van den Eertwegh, Alfons Jm; de Gruijl, Tanja D.
Afiliação
  • Santegoets SJ; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Stam AG; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands ; Department of Pathology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Lougheed SM; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Gall H; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Jooss K; Cell Genesys Inc, South San Francisco, CA USA.
  • Sacks N; Cell Genesys Inc, South San Francisco, CA USA.
  • Hege K; Cell Genesys Inc, South San Francisco, CA USA.
  • Lowy I; Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, CT USA.
  • Scheper RJ; Department of Pathology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Gerritsen WR; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • van den Eertwegh AJ; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • de Gruijl TD; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
J Immunother Cancer ; 2: 31, 2014.
Article em En | MEDLINE | ID: mdl-26196012

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Immunother Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Immunother Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Holanda